ConductScience.org, home

Paper9607064

The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model.

Willems RJ and 6 others. Vaccine, 1998. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model. Papers, record 9607064. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9607064

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model.
PubMed
Journal
Vaccine
PubMed
Year
1998
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
1.09
iCite
Revised in PubMed
2019-07-28
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Willems RJR J
2Kamerbeek JJ
3Geuijen CAC A
4Top JJ
5Gielen HH
6Gaastra WW
7Mooi FRF R

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BordetellaMajor topic
Bordetella InfectionsMajor topic
Bordetella pertussisMajor topic
Pertussis VaccineMajor topic
Respiratory Tract InfectionsMajor topic
Whooping CoughMajor topic
Animals
Female
Mice
Mice, Inbred BALB C

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in9682386The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in respiratory mouse model.https://conductscience.org/library/papers/9682386

Source PubMed

Download CSV of comments and corrections

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
38543887Pertussis Vaccines Scarcely Provide Protection against Bordetella parapertussis Infection in Children-A Systematic Review and Meta-Analysis.Vaccines (Basel)2024https://conductscience.org/library/papers/38543887PubMed
35103810Non-primate animal models for pertussis: back to the drawing board?Appl Microbiol Biotechnol2022https://conductscience.org/library/papers/35103810PubMed
33178148Evolution and Conservation of Bordetella Intracellular Survival in Eukaryotic Host Cells.Front Microbiol2020https://conductscience.org/library/papers/33178148PubMed
21034823Imperfect vaccine-induced immunity and whooping cough transmission to infants.Vaccine2010https://conductscience.org/library/papers/21034823PubMed
20200027Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.Proc Biol Sci2010https://conductscience.org/library/papers/20200027PubMed
19750010O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.PLoS One2009https://conductscience.org/library/papers/19750010PubMed
19737902The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis.Infect Immun2009https://conductscience.org/library/papers/19737902PubMed
19707559Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection.PLoS One2009https://conductscience.org/library/papers/19707559PubMed
19169359Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity.PLoS One2009https://conductscience.org/library/papers/19169359PubMed
18498620The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.BMC Immunol2008https://conductscience.org/library/papers/18498620PubMed
17935610Comparative gene expression profiling in two congenic mouse strains following Bordetella pertussis infection.BMC Microbiol2007https://conductscience.org/library/papers/17935610PubMed
17698566The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.Infect Immun2007https://conductscience.org/library/papers/17698566PubMed
17494641Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.Clin Vaccine Immunol2007https://conductscience.org/library/papers/17494641PubMed
17487483Lung response to Bordetella pertussis infection in mice identified by gene-expression profiling.Immunogenetics2007https://conductscience.org/library/papers/17487483PubMed
16622195Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology.Infect Immun2006https://conductscience.org/library/papers/16622195PubMed
16177324Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.Infect Immun2005https://conductscience.org/library/papers/16177324PubMed
15664912Genetic control of Bordetella pertussis infection: identification of susceptibility loci using recombinant congenic strains of mice.Infect Immun2005https://conductscience.org/library/papers/15664912PubMed
12540552Role of systemic and mucosal immune responses in reciprocal protection against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.Infect Immun2003https://conductscience.org/library/papers/12540552PubMed
11598073Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.Infect Immun2001https://conductscience.org/library/papers/11598073PubMed
11447159Immunoglobulin A-mediated protection against Bordetella pertussis infection.Infect Immun2001https://conductscience.org/library/papers/11447159PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9607064

GET https://conductscience.org/api/papers/v1/9607064/cited_by?page=2